XML 65 R36.htm IDEA: XBRL DOCUMENT v2.4.1.9
Equity-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2014
Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Weighted average grant date fair value of options
The weighted average fair value of each option granted is estimated on the date of grant using the Black-Scholes option valuation model with the weighted average assumptions during the year ended December 31, 2013 as shown in the table below. No assumptions are presented for the year ended December 31, 2014 as no options were granted during this period.
 
Year Ended
December 31,
 
2013
Risk free interest rate
0.8%
Expected option lives
5 years
Expected volatility
103.2%
Estimated forfeiture rate
10%
Expected dividend yields
Weighted average grant date fair value of options
$1.39
Summary of options granted, exercised, expired and forfeited
A summary of stock options granted, exercised, expired and forfeited under our plans and options outstanding as of, and changes made during, the years ended December 31, 2014 and 2013 (options in thousands):
 
Outstanding
 
Exercisable
 
Number of Options
 
Weighted
Average
Exercise
Price
 
Number of Options
 
Weighted
Average
Exercise
Price
Options outstanding, December 31, 2012
1,857

 
$
3.07

 
605

 
$
2.93

Granted
1,075

 
1.84

 
 
 
 
Exercised
(70
)
 
1.61

 
 
 
 
Expired
(14
)
 
13.56

 
 
 
 
Forfeited
(1,056
)
 
3.16

 
 
 
 
Options outstanding, December 31, 2013
1,792

 
$
2.21

 
410

 
$
2.71

Granted

 

 
 
 
 
Exercised
(50
)
 
0.90

 
 
 
 
Expired
(50
)
 
5.29

 
 
 
 
Forfeited
(342
)
 
2.70

 
 
 
 
Options outstanding, December 31, 2014
1,350

 
$
2.02

 
729

 
$
2.05

Shares authorized under stock option plans, by exercise price range
Additional information as of December 31, 2014 is as follows (options in thousands):
 
Outstanding
 
Exercisable
Range of price
Number
of Options
 
Weighted
Average
Remaining
Contractual
Life (In Years)
 
Weighted
Average
Exercise
Price
 
Number
of Options
 
Weighted
Average
Exercise
Price
$0.90 – $1.51
175

 
7.67
 
$
1.29

 
85

 
$
1.29

$1.52 – $1.96
70

 
3.23
 
1.71

 
70

 
1.71

$1.98 – $2.05
892

 
7.96
 
1.98

 
438

 
1.98

$2.12 – $2.60
97

 
5.50
 
2.34

 
70

 
2.35

$2.68 – $7.68
116

 
6.32
 
3.29

 
66

 
3.50

 
1,350

 
7.36
 
$
2.02

 
729

 
2.05

Schedule of nonvested options activity
A summary of unvested options as of, and changes during the years ended December 31, 2014 and 2013, is presented below (options in thousands):
 
Options
 
Weighted Average
Grant Date
Fair Value
Unvested options outstanding, December 31, 2012
1,252

 
$
2.27

Granted
1,075

 
1.39

Vested
(85
)
 
1.43

Forfeited
(860
)
 
2.25

Unvested options outstanding, December 31, 2013
1,382

 
$
1.57

Granted

 

Vested
(597
)
 
1.46

Forfeited
(163
)
 
2.20

Unvested options outstanding, December 31, 2014
622

 
$
1.51

Stock option compensation expense is allocated
Stock option compensation expense relating to stock option awards is allocated as follows for the years ended December 31, 2014 and 2013 (in thousands):
 
Year Ended December 31,
 
2014
 
2013
General and administrative
$
356

 
$
646

 
$
356

 
$
646


Restricted Stock [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of nonvested options activity
A summary of restricted stock granted, vested, forfeited and unvested outstanding as of, and changes made during, the years ended December 31, 2014 and 2013, is presented below (shares in thousands):
 
Restricted Shares
 
Weighted Average
Grant Price
Unvested restricted shares outstanding, December 31, 2012
1,294

 
$
2.43

Granted
388

 
1.28

Vested
(367
)
 
1.43

Forfeited
(850
)
 
2.56

Unvested restricted shares outstanding, December 31, 2013
465

 
$
2.03

Granted
522

 
1.53

Vested
(122
)
 
1.54

Forfeited
(224
)
 
2.32

Unvested restricted shares outstanding, December 31, 2014
641

 
$
1.61

Stock option compensation expense is allocated
Stock compensation expense relating to restricted stock awards are allocated as follows for the years ended December 31, 2014 and 2013 (in thousands):
 
Year Ended December 31,
 
2014
 
2013
Cost of revenue
$
36

 
$
40

Research and development
12

 
8

Sales and marketing
29

 
56

General and administrative
167

 
453

 
$
244

 
$
557